Macquarie downgrades ZOZO stock to Underperform on LYST acquisition concerns

Macquarie has downgraded ZOZO, Inc. to Underperform from Neutral, reducing its price target to JPY1,180.00 from JPY1,586.51. This downgrade is driven by concerns that ZOZO's acquisition of LYST will negatively impact future profitability, with Macquarie projecting the company's operating profit margin to decline to 28% over the next three years. Furthermore, the firm anticipates a 7.3% year-over-year decrease in ZOZO's Q1 FY2026 operating profit, significantly below the consensus expectation of a 0.1% decline, primarily due to acquisition-related costs.

Analysis

Macquarie has issued a notable downgrade for ZOZO, Inc. (3092:JP), moving its rating from Neutral to Underperform and slashing its price target to JPY 1,180.00 from JPY 1,586.51. The core driver for this bearish revision is the anticipated negative impact of the LYST acquisition on the company's future profitability. Macquarie's analysis projects a significant compression in ZOZO's operating profit margin, forecasting a decline to 28% over the next three years from an expected 30% in fiscal year 2025. This outlook is substantially more pessimistic than the market consensus, particularly for the first quarter of fiscal year 2026, where Macquarie anticipates a 7.3% year-over-year drop in operating profit due to acquisition costs, starkly contrasting with the consensus expectation of a mere 0.1% decline. The change in analyst coverage may also signal a fresh and more critical evaluation of the company's strategic direction and its financial implications.

Key Decisions for Investors

• Given the significant price target reduction and a forecast well below consensus, investors should re-evaluate long positions in ZOZO, Inc. due to the identified risks of margin erosion and earnings underperformance linked to the LYST acquisition.
• Potential investors should exercise caution, as Macquarie's analysis presents a compelling bear case; it would be prudent to await further clarity on the integration costs and actual profit impact in subsequent earnings reports before initiating a position.
• Monitor ZOZO's upcoming financial statements closely, focusing specifically on operating profit margins and management commentary regarding acquisition-related synergies and costs to validate or disprove Macquarie's bearish thesis.